Skip to main content
Clinical Trials/NCT02923037
NCT02923037TerminatedNot Applicable

Feasibility and Preliminary Efficacy of Hatha Yoga in Breast Cancer Survivors: Pilot Study

Vanderbilt-Ingram Cancer Center1 site in 1 country27 target enrollmentStarted: September 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
27
Locations
1
Primary Endpoint
Assess safety

Study Overview

Brief Summary

This pilot clinical trial studies Hatha yoga in reducing physical and emotional problems in breast cancer survivors with stage II-III lymphedema. Yoga practices may benefit breast cancer survivors with lymphedema as they directly support lymph transport (postures, breathing, relaxation) and emotional well-being (relaxation, meditation).

Detailed Description

PRIMARY OBJECTIVES:

I. To determine the feasibility of a modified yoga program for breast cancer survivors (BCS) with lymphedema.

II. To identify and document required modifications for a safe and feasible practice.

III. To obtain recruitment estimates and determine barriers to recruitment (acceptability).

IV. To evaluate implementation fidelity (adherence and competence) and barriers to implementation fidelity.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Lymphedema Group:
  • •Lymphedema, symptomatic of stage II or III based upon screening responses; or L-Dex reading of ≥ 7 at initial visit,
  • •> 3 months (mths) post-breast cancer treatment
  • •No active cancer
  • •Has compression sleeve
  • •Ability to understand English in order to complete questionnaires
  • •Willing to do guided and home yoga practice
  • •Willing and able to provide informed consent as demonstrated by passing screening tool questions that includes the Short Portable Mental Status Questionnaire
  • •Medical clearance
  • •Reliable transportation to the study site
  • •No Lymphedema Group:
  • •No known lymphedema or intermittent swelling, not symptomatic of Stage II or III lymphedema (L-Dex ≥ 7)
  • •>3 months post- breast cancer treatment
  • •No active cancer
  • •Ability to understand English in order to complete questionnaires
  • •Willing to do guided and home Yoga practice
  • •Willing and able to provide informed consent as demonstrated by passing screening tool questions that includes the Short Portable Mental Status Questionnaire
  • •Medical clearance
  • •Reliable transportation to the study site.

Exclusion Criteria

  • •(Both Groups):
  • •Active cancer
  • •Undergoing radiation therapy or chemotherapy
  • •Medical conditions that would prohibit the safe implementation of a yoga practice (e.g., vertigo, compromised mental status)
  • •Active yoga practice < 3 months
  • •Currently undergoing phase I complete decongestive therapy (CDT)
  • •Inability to complete study forms

Arms & Interventions

Supportive Care (Yoga)

Experimental

Patients undergo an initial yoga evaluation for 60 minutes. Patients then undergo their first guided yoga practice session for 30-60 minutes and subsequent guided yoga sessions for 30-90 minutes 3 times a week for 4 weeks, and twice a week for an additional 4 weeks. Patients are also encouraged to complete home yoga practice for 30 to 90 minutes every day for 8 weeks. They will have tape measurement of arms and ldex measurement of arms. Quality-of-Life Assessment will also be made.

Intervention: Yoga (Procedure)

Supportive Care (Yoga)

Experimental

Patients undergo an initial yoga evaluation for 60 minutes. Patients then undergo their first guided yoga practice session for 30-60 minutes and subsequent guided yoga sessions for 30-90 minutes 3 times a week for 4 weeks, and twice a week for an additional 4 weeks. Patients are also encouraged to complete home yoga practice for 30 to 90 minutes every day for 8 weeks. They will have tape measurement of arms and ldex measurement of arms. Quality-of-Life Assessment will also be made.

Intervention: tape measurement of arm (Other)

Supportive Care (Yoga)

Experimental

Patients undergo an initial yoga evaluation for 60 minutes. Patients then undergo their first guided yoga practice session for 30-60 minutes and subsequent guided yoga sessions for 30-90 minutes 3 times a week for 4 weeks, and twice a week for an additional 4 weeks. Patients are also encouraged to complete home yoga practice for 30 to 90 minutes every day for 8 weeks. They will have tape measurement of arms and ldex measurement of arms. Quality-of-Life Assessment will also be made.

Intervention: Quality-of-Life Assessment (Other)

Supportive Care (Yoga)

Experimental

Patients undergo an initial yoga evaluation for 60 minutes. Patients then undergo their first guided yoga practice session for 30-60 minutes and subsequent guided yoga sessions for 30-90 minutes 3 times a week for 4 weeks, and twice a week for an additional 4 weeks. Patients are also encouraged to complete home yoga practice for 30 to 90 minutes every day for 8 weeks. They will have tape measurement of arms and ldex measurement of arms. Quality-of-Life Assessment will also be made.

Intervention: ldex measurement of arms (Other)

Outcomes

Primary Outcomes

Assess safety

Time Frame: Up to 8 weeks

Number of participants with treatment-related adverse events as assessed by the CTCAE v4.0

Pose Modifications

Time Frame: Up to 8 weeks

number of poses requiring modifications as indicated in the modification form

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sheila Ridner

Principal Investigator

Vanderbilt-Ingram Cancer Center

Study Sites (1)

Loading locations...

Similar Trials